Annexon Biosciences (ANNX)
NASDAQ:ANNX
US Market
Holding ANNX?
Track your performance easily

Annexon Biosciences (ANNX) Financial Statements

843 Followers

Annexon Biosciences Financial Overview

Annexon Biosciences's market cap is currently ―. The company's EPS TTM is $-1.22; its P/E ratio is -6.18; Annexon Biosciences is scheduled to report earnings on November 18, 2024, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--$ 1.60M$ 600.00K$ 600.00K
Gross Profit--$ 400.00K$ 600.00K$ 600.00K
EBIT$ -29.61M$ -28.57M$ -30.01M$ -34.78M$ -37.69M
EBITDA$ -27.62M$ -28.03M$ -29.47M$ -34.55M$ 0.00
Net Income Common Stockholders$ -29.61M$ -25.18M$ -27.89M$ -32.48M$ -35.19M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 368.70M$ 264.95M$ 259.72M$ 165.27M$ 192.94M
Total Assets$ 406.08M$ 304.07M$ 297.67M$ 203.82M$ 233.01M
Total Debt$ 30.20M$ 30.79M$ 31.36M$ 31.51M$ 32.01M
Net Debt$ -338.50M$ -234.16M$ -228.36M$ -133.76M$ -160.92M
Total Liabilities$ 45.01M$ 41.66M$ 47.12M$ 46.98M$ 48.29M
Stockholders Equity$ 361.08M$ 262.38M$ 250.56M$ 156.84M$ 184.75M
Cash Flow-
Free Cash Flow$ -21.71M$ -28.27M$ -23.48M$ -28.31M-
Operating Cash Flow$ -21.71M$ -28.27M$ -23.48M$ -28.29M-
Investing Cash Flow$ -96.58M$ -77.30M$ -2.18M$ 47.84M-
Financing Cash Flow$ 123.65M$ 32.41M$ 117.60M--
Currency in USD

Annexon Biosciences Earnings and Revenue History

Annexon Biosciences Debt to Assets

Annexon Biosciences Cash Flow

Annexon Biosciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis